Simplex Trading
CRDF icon

Simplex Trading’s Cardiff Oncology CRDF Stock Holding History

Simplex Trading’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.5K Buy
11,400
+10,900
+2,180% +$22.4K ﹤0.01% 6842
2025
Q4 		$1.41K Sell
500
-64,100
-99% -$149K ﹤0.01% 7941
2025
Q3 		$133K Sell
64,600
-7,300
-10% -$20.2K ﹤0.01% 5424
2025
Q2 		$226K Buy
71,900
+46,600
+184% +$142K ﹤0.01% 4382
2025
Q1 		$79K Sell
25,300
-16,400
-39% -$64.9K ﹤0.01% 5309
2024
Q4 		$180K Buy
41,700
+11,100
+36% +$34.7K ﹤0.01% 4616
2024
Q3 		$81K Buy
30,600
+13,500
+79% +$31.9K ﹤0.01% 5429
2024
Q2 		$37K Buy
17,100
+5,900
+53% +$22.2K ﹤0.01% 6357
2024
Q1 		$59K Buy
+11,200
New +$29.8K ﹤0.01% 6107
2023
Q2 		– Sell
-2,800
Closed -$4K – 9103
2023
Q1 		$4K Sell
2,800
-2,000
-42% -$3.43K ﹤0.01% 8151
2022
Q4 		$6K Sell
4,800
-22,600
-82% -$32.4K ﹤0.01% 7916
2022
Q3 		$42K Sell
27,400
-27,000
-50% -$65K ﹤0.01% 6669
2022
Q2 		$119K Buy
54,400
+33,200
+157% +$55.6K ﹤0.01% 5326
2022
Q1 		$52K Buy
21,200
+13,600
+179% +$48.1K ﹤0.01% 7062
2021
Q4 		$45K Buy
7,600
+600
+9% +$3.58K ﹤0.01% 7390
2021
Q3 		$46K Hold
7,000
– – ﹤0.01% 7591
2021
Q2 		$46K Buy
7,000
+6,584
+1,583% +$55.8K ﹤0.01% 7735
2021
Q1 		$385K Buy
416
+388
+1,386% +$4.71K ﹤0.01% 3765
2020
Q4 		$50K Sell
28
-184
-87% -$3.23K ﹤0.01% 6175
2020
Q3 		$300K Buy
+212
New +$1.4K ﹤0.01% 3598

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Simplex Trading's CRDF Position: Q1 2026 in Review

Simplex Trading opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 16,454 shares worth $26.7K. The stake represents ﹤0.01% of the portfolio and ranks #6510 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CRDF as recently as Q3 2025.

Simplex Trading first reported a position in CRDF in Q4 2015 and has held it in 25 quarters since. The position peaked at $387K in Q1 2025. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Simplex Trading held 16,454 shares of Cardiff Oncology worth $26.7K as of Q1 2026.
  • Cardiff Oncology was a new Simplex Trading position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6510 holding.
  • Simplex Trading first reported a position in Cardiff Oncology in Q4 2015 and has held it in 25 quarters since.
  • Simplex Trading's Cardiff Oncology position peaked at $387K in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.